查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1722713

2025 年至 2033 年肿瘤学体内 CRO 市场报告，按适应症（血癌、实体瘤等）、模型（同基因、异种移植、患者来源异种移植 (PDX) 等）、应用（医院、復健中心）和地区划分

Oncology Based In-Vivo CRO Market Report by Indication (Blood Cancer, Solid Tumors, and Others), Model (Syngeneic, Xenograft, Patient Derived Xenograft (PDX), and Others), Application (Hospitals, Rehabilitation Centers), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3个工作天内

价格

2024 年，全球基于肿瘤的体内 CRO 市场规模达到 13 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 24 亿美元，2025-2033 年期间的成长率 (CAGR) 为 6.55%。癌症发病率的上升、法规遵循、技术的持续进步以及个人化医疗需求的激增正在推动市场成长。

肿瘤学是指利用活检、内视镜检查、X射线、电脑断层扫描 (CT)、磁振造影 (MRI)、正子断层扫描 (PET) 和超音波来研究、诊断和治疗癌症的医学分支。它为患者提供荷尔蒙疗法、免疫疗法、放射疗法和口服疗法，以耐受和减轻癌症的副作用。目前，由于合约研究组织 (CRO) 开发了多种用于治疗癌症的试验化合物，全球对基于肿瘤学的体内 CRO 的需求正在增加。

基于肿瘤学的体内CRO市场趋势：

全球癌症发生率的不断上升是推动市场发展的关键因素之一。此外，全球多个国家的政府都在大力投资研发活动。这一点，加上合约研究组织（CRO）在癌症治疗方面的专业知识不断提高，正在推动市场的成长。此外，操纵脱氧核糖核酸（DNA）和改变生物体特性的基因工程创新也不断增加。再加上人们对调节细胞增殖、生长和分化的致癌基因研究的日益关注，这对市场产生了积极的影响。除此之外，药品的广泛普及以及医疗保健产业的不断扩张，正在催化全球对基于肿瘤的体内 CRO 的需求。除此之外，与内部研究相比，合约研究组织 (CRO) 提供的成本效益为行业投资者提供了丰厚的成长机会。此外，医疗保健行业也越来越多地采用远距医疗和虚拟临床试验来确保癌症患者的安全。预计这将促进市场的成长。

本报告回答的关键问题

  • 2024 年全球肿瘤体内 CRO 市场规模？ 2025 年至 2033 年期间全球肿瘤体内 CRO 市场的预期成长率为何？
  • 推动全球肿瘤学体内 CRO 市场发展的关键因素有哪些？
  • COVID-19 对全球基于肿瘤的体内 CRO 市场有何影响？
  • 根据适应症，全球肿瘤学体内 CRO 市场如何分布？
  • 根据该模型，全球肿瘤学体内 CRO 市场的分布如何？
  • 全球肿瘤学体内 CRO 市场的关键区域有哪些？
  • 全球肿瘤学体内 CRO 市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球肿瘤学体内CRO市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依指标

  • 血癌
  • 实体肿瘤
  • 其他的

第七章：市场区隔：依模型

  • 同基因
  • 异种移植
  • 患者来源的异种移植（PDX）
  • 其他的

第 8 章：市场区隔：按应用

  • 医院
  • 復健中心

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第十章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Champions Oncology Inc.
    • Charles River Laboratories International Inc.
    • Crown Bioscience Inc.
    • Eurofins Scientific
    • Evotec SE
    • ICON Plc
    • Labcorp Drug Development (Laboratory Corporation of America Holdings)
    • Living Tumor Laboratory
    • Taconic Biosciences Inc.
    • The Jackson Laboratory
    • WuXi AppTec
    • Xentech
Product Code: SR112025A5438

The global oncology based in-vivo CRO market size reached USD 1.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.4 Billion by 2033, exhibiting a growth rate (CAGR) of 6.55% during 2025-2033. The rising prevalence of cancer, regulatory compliances, ongoing technological advancements, and the surging demand for personalized medicines are driving the market growth.

Oncology refers to a branch of medicine that studies, diagnoses, and treats cancer using biopsy, endoscopy, X-ray, computed tomography (CT) scanning, magnetic resonance imaging (MRI), positron emission tomography (PET) scanning, and ultrasound. It offers hormonal therapy, immunotherapy, radiotherapy, and oral therapies to patients for tolerating and easing the side effects of cancer. At present, there is a rise in the demand for oncology based in-vivo CRO across the globe due to the development of several investigational compounds by contract research organizations (CROs) for treating cancer.

Oncology Based In-Vivo CRO Market Trends:

The growing prevalence of cancer around the world represents one of the key factors driving the market. Moreover, governments of several countries across the globe are extensively investing in research and development (R&D) activities. This, along with the rising expertise in cancer treatment by contract research organizations (CROs), is propelling the growth of the market. In addition, there is an increase in the innovation of genetic engineering for manipulating deoxyribonucleic acid (DNA) and altering the characteristics of organisms. This, coupled with the growing focus on oncogene study to regulate proliferation, growth, and differentiation of cells, is positively influencing the market. Besides this, the wide availability of medicines, along with the expanding healthcare industry, is catalyzing the demand for oncology based in-vivo CRO worldwide. Apart from this, the cost-efficiency offered by contract research organizations (CROs) compared to an in-house study is offering lucrative growth opportunities to industry investors. Additionally, there is an increase in the adoption of telehealth and virtual clinical trials in the healthcare industry for ensuring the safety of cancer patients. This is projected to bolster the growth of the market.

Key Market Segmentation:

Breakup by Indication:

  • Blood Cancer
  • Solid Tumors
  • Others

Breakup by Model:

  • Syngeneic
  • Xenograft
  • Patient Derived Xenograft (PDX)
  • Others

Breakup by Application:

  • Hospitals
  • Rehabilitation Centers

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Champions Oncology Inc., Charles River Laboratories International Inc., Crown Bioscience Inc., Eurofins Scientific, Evotec SE, ICON Plc, Labcorp Drug Development (Laboratory Corporation of America Holdings), Living Tumor Laboratory, Taconic Biosciences Inc., The Jackson Laboratory, WuXi AppTec and Xentech.

Key Questions Answered in This Report

  • 1.What was the size of the global oncology based in-vivo CRO market in 2024?
  • 2.What is the expected growth rate of the global oncology based in-vivo CRO market during 2025-2033?
  • 3.What are the key factors driving the global oncology based in-vivo CRO market?
  • 4.What has been the impact of COVID-19 on the global oncology based in-vivo CRO market?
  • 5.What is the breakup of the global oncology based in-vivo CRO market based on the indication?
  • 6.What is the breakup of the global oncology based in-vivo CRO market based on the model?
  • 7.What are the key regions in the global oncology based in-vivo CRO market?
  • 8.Who are the key players/companies in the global oncology based in-vivo CRO market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Oncology Based In-Vivo CRO Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Indication

  • 6.1 Blood Cancer
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Solid Tumors
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Model

  • 7.1 Syngeneic
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Xenograft
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Patient Derived Xenograft (PDX)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Rehabilitation Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Champions Oncology Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Charles River Laboratories International Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Crown Bioscience Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Eurofins Scientific
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Evotec SE
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 ICON Plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Labcorp Drug Development (Laboratory Corporation of America Holdings)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Living Tumor Laboratory
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Taconic Biosciences Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 The Jackson Laboratory
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 WuXi AppTec
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12 Xentech
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Oncology Based In-Vivo CRO Market: Major Drivers and Challenges
  • Figure 2: Global: Oncology Based In-Vivo CRO Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Oncology Based In-Vivo CRO Market: Breakup by Indication (in %), 2024
  • Figure 5: Global: Oncology Based In-Vivo CRO Market: Breakup by Model (in %), 2024
  • Figure 6: Global: Oncology Based In-Vivo CRO Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Oncology Based In-Vivo CRO Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Oncology Based In-Vivo CRO (Blood Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Oncology Based In-Vivo CRO (Blood Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Oncology Based In-Vivo CRO (Solid Tumors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Oncology Based In-Vivo CRO (Solid Tumors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Oncology Based In-Vivo CRO (Other Indications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Oncology Based In-Vivo CRO (Other Indications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Oncology Based In-Vivo CRO (Syngeneic) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Oncology Based In-Vivo CRO (Syngeneic) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Oncology Based In-Vivo CRO (Xenograft) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Oncology Based In-Vivo CRO (Xenograft) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Oncology Based In-Vivo CRO (Patient Derived Xenograft (PDX)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Oncology Based In-Vivo CRO (Patient Derived Xenograft (PDX)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Oncology Based In-Vivo CRO (Other Models) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Oncology Based In-Vivo CRO (Other Models) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Oncology Based In-Vivo CRO (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Oncology Based In-Vivo CRO (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Oncology Based In-Vivo CRO (Rehabilitation Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Oncology Based In-Vivo CRO (Rehabilitation Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: North America: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: North America: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: United States: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: United States: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Canada: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Canada: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Asia-Pacific: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Asia-Pacific: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: China: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: China: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Japan: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Japan: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: India: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: India: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: South Korea: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: South Korea: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Australia: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Australia: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Indonesia: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Indonesia: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Others: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Others: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Europe: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Europe: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Germany: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Germany: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: France: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: France: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: United Kingdom: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: United Kingdom: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Italy: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Italy: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Spain: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Spain: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Russia: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Russia: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Others: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Others: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Latin America: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Latin America: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Brazil: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Brazil: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Mexico: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Mexico: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Middle East and Africa: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Middle East and Africa: Oncology Based In-Vivo CRO Market: Breakup by Country (in %), 2024
  • Figure 74: Middle East and Africa: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Global: Oncology Based In-Vivo CRO Industry: SWOT Analysis
  • Figure 76: Global: Oncology Based In-Vivo CRO Industry: Value Chain Analysis
  • Figure 77: Global: Oncology Based In-Vivo CRO Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Oncology Based In-Vivo CRO Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Indication (in Million USD), 2025-2033
  • Table 3: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Model (in Million USD), 2025-2033
  • Table 4: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Oncology Based In-Vivo CRO Market: Competitive Structure
  • Table 7: Global: Oncology Based In-Vivo CRO Market: Key Players